Cardiovascular magnetic resonance demonstrates structural cardiac changes following transjugular intrahepatic portosystemic shunt
Standard
Cardiovascular magnetic resonance demonstrates structural cardiac changes following transjugular intrahepatic portosystemic shunt. / Radunski, Ulf K; Kluwe, Johannes; Klein, Malte; Galante, Antonio; Lund, Gunnar K; Sinning, Christoph; Bohnen, Sebastian; Tahir, Enver; Starekova, Jitka; Bannas, Peter; Stehning, Christian; Adam, Gerhard; Lohse, Ansgar W; Blankenberg, Stefan; Muellerleile, Kai; Benten, Daniel.
In: SCI REP-UK, Vol. 11, No. 1, 12719, 16.06.2021.Research output: SCORING: Contribution to journal › SCORING: Journal article › Research › peer-review
Harvard
APA
Vancouver
Bibtex
}
RIS
TY - JOUR
T1 - Cardiovascular magnetic resonance demonstrates structural cardiac changes following transjugular intrahepatic portosystemic shunt
AU - Radunski, Ulf K
AU - Kluwe, Johannes
AU - Klein, Malte
AU - Galante, Antonio
AU - Lund, Gunnar K
AU - Sinning, Christoph
AU - Bohnen, Sebastian
AU - Tahir, Enver
AU - Starekova, Jitka
AU - Bannas, Peter
AU - Stehning, Christian
AU - Adam, Gerhard
AU - Lohse, Ansgar W
AU - Blankenberg, Stefan
AU - Muellerleile, Kai
AU - Benten, Daniel
PY - 2021/6/16
Y1 - 2021/6/16
N2 - Transjugular intrahepatic portosystemic shunt (TIPS) reduces portal hypertension in patients with liver cirrhosis. The exact cardiac consequences of subsequent increase of central blood volume are unknown. Cardiovascular magnetic resonance (CMR) imaging is the method of choice for quantifying cardiac volumes and ventricular function. The aim of this study was to investigate effects of TIPS on the heart using CMR, laboratory, and imaging cardiac biomarkers. 34 consecutive patients with liver cirrhosis were evaluated for TIPS. Comprehensive CMR with native T1 mapping, transthoracic echocardiography, and laboratory biomarkers were assessed before and after TIPS insertion. Follow-up (FU) CMR was obtained in 16 patients (47%) 207 (170-245) days after TIPS. From baseline (BL) to FU, a significant increase of all indexed cardiac chamber volumes was observed (all P < 0.05). Left ventricular (LV) end-diastolic mass index increased significantly from 45 (38-51) to 65 (51-73) g/m2 (P = < 0.01). Biventricular systolic function, NT-proBNP, high-sensitive troponin T, and native T1 time did not differ significantly from BL to FU. No patient experienced cardiac decompensation following TIPS. In conclusion, in patients without clinically significant prior heart disease, increased cardiac preload after TIPS resulted in increased volumes of all cardiac chambers and eccentric LV hypertrophy, without leading to cardiac impairment during follow-up in this selected patient population.
AB - Transjugular intrahepatic portosystemic shunt (TIPS) reduces portal hypertension in patients with liver cirrhosis. The exact cardiac consequences of subsequent increase of central blood volume are unknown. Cardiovascular magnetic resonance (CMR) imaging is the method of choice for quantifying cardiac volumes and ventricular function. The aim of this study was to investigate effects of TIPS on the heart using CMR, laboratory, and imaging cardiac biomarkers. 34 consecutive patients with liver cirrhosis were evaluated for TIPS. Comprehensive CMR with native T1 mapping, transthoracic echocardiography, and laboratory biomarkers were assessed before and after TIPS insertion. Follow-up (FU) CMR was obtained in 16 patients (47%) 207 (170-245) days after TIPS. From baseline (BL) to FU, a significant increase of all indexed cardiac chamber volumes was observed (all P < 0.05). Left ventricular (LV) end-diastolic mass index increased significantly from 45 (38-51) to 65 (51-73) g/m2 (P = < 0.01). Biventricular systolic function, NT-proBNP, high-sensitive troponin T, and native T1 time did not differ significantly from BL to FU. No patient experienced cardiac decompensation following TIPS. In conclusion, in patients without clinically significant prior heart disease, increased cardiac preload after TIPS resulted in increased volumes of all cardiac chambers and eccentric LV hypertrophy, without leading to cardiac impairment during follow-up in this selected patient population.
KW - Aged
KW - Cardiac Output
KW - Cardiac Volume
KW - Cardiomyopathies/diagnosis
KW - Female
KW - Heart/diagnostic imaging
KW - Heart Failure/diagnosis
KW - Humans
KW - Liver Cirrhosis/surgery
KW - Magnetic Resonance Imaging
KW - Male
KW - Middle Aged
KW - Portasystemic Shunt, Transjugular Intrahepatic/adverse effects
KW - Treatment Outcome
U2 - 10.1038/s41598-021-92064-8
DO - 10.1038/s41598-021-92064-8
M3 - SCORING: Journal article
C2 - 34135410
VL - 11
JO - SCI REP-UK
JF - SCI REP-UK
SN - 2045-2322
IS - 1
M1 - 12719
ER -